Bisantrene
- Generic Name
- Bisantrene
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C22H22N8
- CAS Number
- 78186-34-2
- Unique Ingredient Identifier
- 39C34M111K
- Associated Conditions
- -
- Associated Therapies
- -
Bisantrene Combination for Resistant AML
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2023-11-28
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 29
- Registration Number
- NCT04989335
- Locations
- 🇮🇱
Chaim Sheba Medical Center, Ramat Gan, Israel
Bisantrene for Relapsed /Refractory AML
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-01-29
- Last Posted Date
- 2020-08-07
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT03820908
- Locations
- 🇮🇱
Chaim Sheba Medical Center, Ramat Gan, Israel
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath